Phase I bioequivalence study of controlled-release pregabalin 150mg once daily versus immediate-release pregabalin 50mg 3 times daily
Latest Information Update: 10 Dec 2012
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Pharmacokinetics
- 10 Dec 2012 New trial record